Banka BioLoo
- Market cap
- ₹ 71 Cr.
- P/E
- 106.2x
- P/B
- 1.83x
- 52-week range
- 41 – 96.58
- ROE
- 2%
- ROCE
- 5%
- Dividend yield
- 0%
- Debt / equity
- 1.03
- Sector
- Construction
- Industry
- Civil Construction
- Listed on
- NSE
About
Banka BioLoo Limited is an India-based company. The Company is engaged in the business of manufacturing, supplying and installation of Bio toilets, setting up Fecal Sludge Treatment Plants (FSTPs), wastewater treatment plants, Effluent treatment plants and their operation and maintenance. The Company's products include Bio-Digester, Bio-Toilets, FootLoo, Urban Sewage Treatment Plants, Urban SaaS by Megaliter, and Johkasou. The Company serves various clients including multinational corporations, small and medium-sized enterprises (SMEs), and non-profit organizations. The Company provides wastewater treatment to schools, hotels and hospitals, residential complexes, businesses and retail centers. The Company’s subsidiary is Enzotech Solutions Private Limited.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Civil Construction: 182 companies →Banka BioLoo against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)106.2 against a typical 14.4: pricier than most peers (1st = cheapest).170th of 181
- Sales growth−5.3% against a typical +8.6% from a year earlier.103rd of 147
- Profit growth−500% against a typical 0% from a year earlier.125th of 130
- Share price, 3 months−31.3% against a typical −13.1%.147th of 164
- Size₹ 71.1 Cr. market value against a typical ₹ 148 Cr. (1st = largest).105th of 156
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 13 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 26 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period and quarter ended March 31, 2026, and other business matters |
| 12 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 14 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 8 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
| 28 May 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11 | 14 | 16 | 13 | 12 | 14 | 15 | 11 | 13 | 15 | 18 | 11 |
| Expenses | 9 | 12 | 15 | 11 | 17 | 14 | 15 | 11 | 13 | 14 | 14 | 9 |
| Operating Profit | 2 | 2 | 1 | 2 | −4 | 0 | −0 | 0 | −0 | 1 | 3 | 2 |
| OPM % | 20% | 12.8% | 6.3% | 13.5% | −36.1% | 0.2% | −1.2% | 3.1% | −0.1% | 9.6% | 19% | 17.2% |
| Other Income | 0 | 0 | 0 | 0 | −0 | 0 | 0 | 1 | 0 | 0 | −0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | −0 | 0 | −6 | −1 | −2 | −0 | −2 | −0 | 2 | −0 |
| Tax % | −5.2% | −3% | 166.7% | 21.6% | −0.8% | −2% | −12% | −100% | −30.6% | −14.3% | −1.9% | −55.6% |
| Net Profit | 1 | 1 | −0 | 0 | −6 | −1 | −2 | 0 | −1 | −0 | 2 | −0 |
| EPS in Rs | 1.12 | 0.65 | −0.22 | 0.27 | −5.65 | −1.35 | −1.49 | 0.01 | −0.99 | −0.14 | 1.45 | −0.01 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 13%
- 3 Years
- 10%
- TTM
- 8%
- 10 Years
- —
- 5 Years
- −22%
- 3 Years
- −38%
- TTM
- 107%
- 10 Years
- —
- 5 Years
- 4%
- 3 Years
- 4%
- TTM
- —
- 10 Years
- —
- 5 Years
- −2%
- 3 Years
- −8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Banka BioLoo | ₹ 62.15 | ₹ 71 Cr. | 106.2x | 1.8x | 2% | — |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 226x | 3.8x | 1.6% | 1.5% |
| Urban Company | ₹ 132.65 | ₹ 20,457 Cr. | — | 8.9x | −11.9% | −15.1% |
| Indegene | ₹ 570.00 | ₹ 13,763 Cr. | 29.5x | 3.9x | 13.9% | 11.4% |
| BLS International Services | ₹ 208.70 | ₹ 8,593 Cr. | 14.2x | 3.9x | 32.7% | 24.1% |
| Axiscades Technologies | ₹ 1,915.00 | ₹ 8,154 Cr. | 83.3x | 9.1x | 10.5% | 6.2% |
Management
- Sanjay Banka
- Executive Chairman of the Board
- Vishal Murarka
- Chief Executive Officer, Executive Director
- Venkata Tadepalli Rama Krishna
- Chief Financial Officer, Executive Director
- Y. Sri Bala Aditya
- Compliance Officer, Company Secretary
- Namita Banka
- Managing Director
- Akhilesh Kumar Tripathi
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.